Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Fatigue 6 Neoplasms 5 Breast Neoplasms 5 Anxiety Disorders 3 Psychological Well-Being 2 Pain 2 Lung Neoplasms 2 Gastrointestinal Neoplasms 2 Esophageal Neoplasms 2 Depression 2 Caregiver Burden 2 Uterine Neoplasms 1 Tuberous Sclerosis 1 Substance-Related Disorders 1 Sleep Wake Disorders 1 Sleep Initiation and Maintenance Disorders 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Ovarian Neoplasms 1 Neoplasm Regression, Spontaneous 1 Multiple Myeloma 1 Malignant Hepatobiliary Neoplasm 1 Lymphoma 1 Leukemia 1 Hematopoietic Cell Transplantation Recipient 1 Glioblastoma 1 Colorectal Neoplasms 1 Cognitive Dysfunction 1 Chronic Pain 1

Interventions

Radiosurgery 28 Magnetic Resonance Spectroscopy 27 Dexmedetomidine 8 Radiotherapy 7 Radiation 7 Proton Therapy 7 Mental Status and Dementia Tests 7 Magnetic Resonance Imaging 7 Exercise 6 Surgical Procedures, Operative 5 Specimen Handling 5 Saline Solution 5 Blood Specimen Collection 5 Bevacizumab 5 Remifentanil 4 Radiotherapy, Intensity-Modulated 4 Propofol 4 alovudine 3 Transcranial Magnetic Stimulation 3 Temozolomide 3 Resistance Training 3 Methods 3 Mannitol 3 Diffusion Tensor Imaging 3 Cognitive Training 3 gadobutrol 2 gadobenic acid 2 Yoga 2 Vitamin D 2 Ultrasonography 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Brain Neoplasms × Acceptance and Commitment Therapy × Clear all

NCT04722237 2023-08-31

ACT NOW

Nottingham University Hospitals NHS Trust

Phase NA Unknown

Brain Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡